Medicxi Ventures Management as of Dec. 31, 2024
Portfolio Holdings for Medicxi Ventures Management
Medicxi Ventures Management holds 5 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 63.2 | $334M | 20M | 16.75 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 13.9 | $74M | 2.9M | 25.70 | |
| Phathom Pharmaceuticals (PHAT) | 11.5 | $61M | 7.5M | 8.12 | |
| Rapt Therapeutics | 6.7 | $35M | 22M | 1.58 | |
| Aura Biosciences (AURA) | 4.7 | $25M | 3.0M | 8.22 |
